CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC and OXFORD GLYCOSCIENCES PLC and THE BANK OF NEW YORK As Depositary and OWNERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY RECEIPTS Amendment No. 1 dated as of______________, 2003 (to OGS Deposit Agreement...Ogs Deposit Agreement • February 27th, 2003 • Cambridge Antibody Technology Group PLC • Services-commercial physical & biological research
This AMENDMENT NO. 1, dated as of __________, 2003 to the OGS Deposit Agreement (as hereinafter defined), among CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC, incorporated under the laws of England and Wales (herein called the “Company”), OXFORD GLYCOSCIENCES PLC, incorporated under the laws of England and Wales (herein called “OGS”), THE BANK OF NEW YORK, a New York banking corporation (herein called the “Depositary”), and all Owners and holders from time to time of American Depositary Receipts issued hereunder.
